Study Comparing the Effects of Esomeprazole Adminstered Orally and Intravenously on Basal and Pentrigastrin-stimulated Acid Output in Subjects With Symptoms of Gastroesophageal Reflux Disease (GERD)

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 30, 2002

Primary Completion Date

November 30, 2002

Study Completion Date

November 30, 2002

Conditions

Gastroesophageal Reflux Disease

Interventions

DRUG

Esomeprazole

40mg Intravenous infusion over 3 minutes

DRUG

Esomeprazole

40mg Oral